Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EDIT - Editas Medicine Q2 2022 Earnings Preview
August, 02 2022 11:58 AM
Editas Medicine Inc.
Editas Medicine ( NASDAQ: EDIT ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is -$0.80 (+1.2% Y/Y) and the consensus Revenue Estimate is $4.29M (+1028.9% Y/Y). Over the last 1 year, EDIT has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 4 upward revisions and 4 downward. Revenue estimates have seen 0 upward revisions and 2 downward. For further details see:
Editas Medicine Q2 2022 Earnings Preview
Stock Information
Company Name:
Editas Medicine Inc.
Stock Symbol:
EDIT
Market:
NASDAQ
Website:
editasmedicine.com
Get EDIT Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .